| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/14/2002 | EP1231210A2 Azole antifungal agents, processes for the preparation thereof, and intermediates |
| 08/14/2002 | EP1231208A2 4-oxocyclic ureas useful as antiarrhythmic and antifibrillatory agents |
| 08/14/2002 | EP1230952A2 Combinations of estrogen and progestogen for preventing and treating skin aging |
| 08/14/2002 | EP1230925A1 Anti-hiv compositions |
| 08/14/2002 | EP1230924A1 Remedies for pigmentation and melanocyte proliferation inhibitors |
| 08/14/2002 | EP1230923A1 Tocotrienols as inhibitors for neovascularisation, cell multiplication, lumen formation and fgf |
| 08/14/2002 | EP1230922A1 Agents for promoting fattening of animals and method of promoting fattening |
| 08/14/2002 | EP1230921A1 Combination treatment for depression |
| 08/14/2002 | EP1230920A1 Food materials useful in preventing and ameliorating metabolic bone diseases and preventives/remedies for metabolic bone diseases comprising these materials |
| 08/14/2002 | EP1230919A2 Use of a composition comprising a retinoid and an erb inhibitor in the preparation of a medicament for the treatment of retinoid skin damage |
| 08/14/2002 | EP1230918A2 An aqueous enteroclysis solution for the treatment of hepatic encephalopathy |
| 08/14/2002 | EP1230916A2 Aqueous medicament preparations for the production of propellant gas-free aerosols |
| 08/14/2002 | EP1230911A1 cosmetic or pharmaceutical preparation |
| 08/14/2002 | EP1230549A2 Method for solubilising optical markers |
| 08/14/2002 | EP1230394A1 Lentiviral vector transduction of hematopoietic stem cells |
| 08/14/2002 | EP1230389A1 Antisense inhibition of pi3 kinase p55 gamma expression |
| 08/14/2002 | EP1230375A1 Inhibiting gene expression with dsrna |
| 08/14/2002 | EP1230364A2 Compositions and methods for the therapy and diagnosis of prostate cancer |
| 08/14/2002 | EP1230360A2 15 human secreted proteins |
| 08/14/2002 | EP1230357A2 Genes differentially expressed in tr1 cells and their use in the manufacture of immunoregulatory compositions |
| 08/14/2002 | EP1230356A2 Pentraxin i and pentraxin receptor, inhibitors of said proteins and pharmaceutical compositions containing said compounds |
| 08/14/2002 | EP1230349A2 Nucleic acids encoding endotheliases, endotheliases and uses thereof |
| 08/14/2002 | EP1230338A1 Continuous-flow method for preparing microparticles |
| 08/14/2002 | EP1230264A1 Therapeutic compositions and methods for treating disease states with mutant forms of myeloid progenitor inhibitory factor-2 (mpif-2) |
| 08/14/2002 | EP1230254A1 Antisense modulation of src-3 expression |
| 08/14/2002 | EP1230252A1 Beta-d-5-thioxylose derivatives, preparation method and therapeutic use |
| 08/14/2002 | EP1230250A2 Aminoalkyl glucosaminide phosphate compounds and their use as adjuvants and immunoeffectors |
| 08/14/2002 | EP1230244A2 Pyrazolecarboxylic acid tricyclic derivatives, preparation and pharmaceutical compositions containing same |
| 08/14/2002 | EP1230243A1 Poycyloalkylpurines as adenosine receptor antagonists |
| 08/14/2002 | EP1230242A1 Use of 9-substituted hypoxanthine derivatives to stimulate regeneration of nervous tissue |
| 08/14/2002 | EP1230241A2 Adenosine receptor antagonists and methods of making and using the same |
| 08/14/2002 | EP1230239A1 Pesticidal aminoheterocyclamide compounds |
| 08/14/2002 | EP1230237A1 Magnesium omeprazole |
| 08/14/2002 | EP1230236A1 Compound with growth hormone releasing properties |
| 08/14/2002 | EP1230235A1 Compounds with antibacterial and antiparasitic properties |
| 08/14/2002 | EP1230232A2 Substituted 4h-chromene and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 08/14/2002 | EP1230230A1 Indeno-, naphtho-, and benzocyclohepta-dihydrothiazole derivatives, the production thereof and their use as anorectic medicaments |
| 08/14/2002 | EP1230227A1 Benzoxa-and benzothiazolyl sulfamates and their use as steroid sulfatase inhibitors |
| 08/14/2002 | EP1230224A1 Substituted 5-benzyl-2,4-diaminopyrimidines |
| 08/14/2002 | EP1230222A1 1-benzylpyrazoles-3-carboxylic acid tricyclic derivatives as cannabinoid receptor antagonists |
| 08/14/2002 | EP1230220A1 Beta-aminoacid compounds useful for inhibiting beta-amyloid peptide release and/or its synthesis |
| 08/14/2002 | EP1230219A1 Aromatic sulfons hydroxamic acid metalloprotease inhibitor |
| 08/14/2002 | EP1230218A1 Positive modulators of nicotinic receptor agonists |
| 08/14/2002 | EP1230217A1 Positive modulators of nicotinic receptor agonists |
| 08/14/2002 | EP1230216A1 Positive modulators of nicotinic receptor agonists |
| 08/14/2002 | EP1230215A1 Pyrrole derivatives as phosphodiesterase vii inhibitors |
| 08/14/2002 | EP1230214A2 Novel genes tzap7/a, tzap7/b and tzap7 involved in t cell activation and uses thereof |
| 08/14/2002 | EP1230210A1 Aminoalcohol derivatives useful for the treatment of gastrointestinal disorders |
| 08/14/2002 | EP1230209A2 Stable salts of novel derivatives of 3,3-diphenylpropylamines |
| 08/14/2002 | EP1229954A1 Method of treating cardio pulmonary diseases with no group compounds |
| 08/14/2002 | EP1229942A1 Method and formula for tumor remission and suppression of cancer |
| 08/14/2002 | EP1229939A1 Use of histamine as a drug delivery enhancing compound for use in transmucosal or transdermal delivery |
| 08/14/2002 | EP1229938A2 Potentiation of prodrug efficacy |
| 08/14/2002 | EP1229934A2 Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents |
| 08/14/2002 | EP1229926A1 Pharmaceutical composition for treatment of diarrhea |
| 08/14/2002 | EP1229925A2 Inhibitors of helicobacter pylori induced gastrointestinal diseases |
| 08/14/2002 | EP1229924A1 Targeted bifunctional molecules and therapies based thereon |
| 08/14/2002 | EP1229922A2 Aplidine treatment of cancers |
| 08/14/2002 | EP1229921A1 Heparanase inhibitors for the treatment of heart failure |
| 08/14/2002 | EP1229920A1 Therapy with 2-5a and interferon |
| 08/14/2002 | EP1229919A2 A method of effecting phosphorylation in eucaryotic cells using thiamine triphosphate |
| 08/14/2002 | EP1229918A2 Pharmaceutical composition comprising a combination of metformin and glibenclamide |
| 08/14/2002 | EP1229917A1 Pharmaceutical compositions and preparations for treatment of metabolic bone disease |
| 08/14/2002 | EP1229916A2 Combination chemotherapy |
| 08/14/2002 | EP1229915A1 Protease inhibitors |
| 08/14/2002 | EP1229914A1 Protease inhibitors |
| 08/14/2002 | EP1229913A1 Substituted 1-benzazepines and derivatives thereof |
| 08/14/2002 | EP1229912A1 Protease inhibitors |
| 08/14/2002 | EP1229911A1 Protease inhibitors |
| 08/14/2002 | EP1229910A1 Integrin receptor antagonists |
| 08/14/2002 | EP1229909A2 Transdermal delivery of lasofoxifene |
| 08/14/2002 | EP1229908A1 USE OF NSAIDs FOR THE TREATMENT OF PANCREATIC CANCER |
| 08/14/2002 | EP1229907A1 Prevention of plaque rupture by acat inhibitors |
| 08/14/2002 | EP1229906A2 Mesoprogestins for the treatment and prevention of benign hormone dependent gynecological disorders |
| 08/14/2002 | EP1229905A2 Transdermal drug delivery devices comprising (r)-(z)-1- azabicyclo[2.2.1]heptan-3-one, o-[3(3-methoxyphenyl)-2-propynyl]oxime |
| 08/14/2002 | EP1229903A1 A method for chemoprevention of prostate cancer |
| 08/14/2002 | EP1229894A1 Cosmetic compositions containing chick pea extract and retinoids |
| 08/14/2002 | EP1229802A1 Food product and process for manufacturing same |
| 08/14/2002 | EP1229795A2 Human chemokine beta-13 |
| 08/14/2002 | EP1229791A2 Active ingredient combination having insecticidal and acaricidal characteristics |
| 08/14/2002 | EP1189922A4 Steroid derivatives |
| 08/14/2002 | EP1087987B1 A compound, wf002, production thereof and use thereof |
| 08/14/2002 | EP1087976B1 Polymorphic clopidogrel hydrogenesulphate form |
| 08/14/2002 | EP1087961B1 Phenoxylpropanolamines, method for the production thereof and pharmaceutical compositions containing the same |
| 08/14/2002 | EP1077718B1 Enhancement of oxazolidinone antibacterial agents activity by arginine derivatives |
| 08/14/2002 | EP1063981B1 Use of selegiline or desmethylselegiline for treating wounds, burns and dermatological damage |
| 08/14/2002 | EP1052967B1 Antiplaque oral composition and method for promoting oral hygiene |
| 08/14/2002 | EP1023039B1 Use of alkylmonoglucosides as molecular vectors |
| 08/14/2002 | EP1014993B1 New use for budesonide and formoterol |
| 08/14/2002 | EP0988038B1 (imidazol-5-yl)methyl-2-quinolinone derivatives as inhibitors of smooth muscle cell proliferation |
| 08/14/2002 | EP0977582B1 Pharmaceutical combined preparations containing erythropoietin and iron preparations |
| 08/14/2002 | EP0973519B1 Inclusion complexes in aqueous solution |
| 08/14/2002 | EP0959898A4 Lactoferrin variants and uses thereof |
| 08/14/2002 | EP0956281B1 Novel modifications to 2-amino-4-(4-fluorobenzylamino)-1-ethoxycarbonyl-aminobenzene and processes for preparing said compound |
| 08/14/2002 | EP0954329B1 Method of killing target cells in harvested cell populations with two immunotoxins |
| 08/14/2002 | EP0944675B1 Stable, aqueous dispersions and stable, water-dispersible dry xanthophyll powder, their production and use |
| 08/14/2002 | EP0937076B1 Substituted oximes, hydrazones and olefins as neurokinin antagonists |
| 08/14/2002 | EP0922054B1 Anticoagulant peptidyl-arginine aldehyde derivatives |
| 08/14/2002 | EP0918750B1 New guanidine derivatives, methods of preparing them and their use as drugs |
| 08/14/2002 | EP0907364B1 Sustained release pharmaceutical compositions comprising a dibenzothiazepine derivative |